Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-10-31T23:34:45.771Z Has data issue: false hasContentIssue false

16 - A Future Agenda for Government–Industry Relations

Published online by Cambridge University Press:  04 December 2009

Michael A. Santoro
Affiliation:
Rutgers University, New Jersey
William C. Weldon
Affiliation:
Chairman of the Board and Chief Executive Officer, Johnson & Johnson
Get access

Summary

INTRODUCTION

Running a research-driven health company in the twenty-first century is both exciting and challenging. We've discovered and developed clinically valuable modern medicines, devices, and diagnostics to improve the lives of millions of patients and their families; these advances also provide economic value by decreasing hospital stays, reducing the use of other expensive healthcare services, and increasing individuals' productivity. Yet, the media and politicians routinely identify the industry as a major societal problem. This image is reinforced because insurers and others are shifting costs, so patients are paying more for medicines than for hospital stays or doctor visits. Consequently, the public's appreciation of our contributions is at an all-time low.

As individuals and governments face real economic challenges in paying for healthcare, the clinical and economic benefits of new medicines often fail to make a favorable impression on the public. Growing premiums, co-payments, and administrative burdens are what the public and many healthcare providers generally focus on, because these are the challenges confronting them daily. And the overall value of new treatments is often obscured by segmental budgeting and cost shifting within our healthcare system. For example, a clinically important new treatment may allow a patient to leave the hospital sooner. Clearly, this is a good thing for patients, as well as their employers, if it allows them to return to work earlier. But financially, this breakthrough can have multiple effects. Insurance companies may save money because outpatient care is less expensive than hospital care.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×